Borderline Personality DisorderEDUC-BPDNCT05428462
Effectiveness of a One-day Psychoeducation Program on Internalized Stigmatization for BPD Patients
An observational study of Borderline Personality Disorder, run by University Hospital, Montpellier at 1 site in France.
Trial summary
Education day on borderline personality disorder (BPD), including a transmission of current scientific knowledge on the disease. A dimensional understanding of BPD is delivered as well as disidentification of oneself to the symptoms of borderline personality disorder (Ducasse 2020 Eur Arch Psychiatry Clin Neurosci). Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Borderline Personality Disorder
- What is being tested?
- Psychoeducation day on borderline personality disorder
- How many people
- 50 participants
- Where
- 1 siteFrance
- Study dates
- 1 Jan 2021to 1 Sep 2021
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Study population: The study population is patients with Borderline Personality disorder assesed according to the SCID II
Who may be able to join
- Patients with Borderline Personality disorder assessed according to SCID II
- Having attended the borderline education day
Who cannot join
- None
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Effectiveness of a One-day Psychoeducation Program on Internalized Stigmatization for Borderline Personality Disorder (BPD) Patients
Education day on borderline personality disorder (BPD), including a transmission of current scientific knowledge on the disease. A dimensional understanding of BPD is delivered as well as disidentification of oneself to the symptoms of borderline personality disorder (Ducasse 2020 Eur Arch Psychiatry Clin Neurosci). The main objective is to evaluate the impact of borderline education day on self-stigma.
Read the detailed description
Borderline personality disorder defined as "a pattern of instability in interpersonal relationships, self-image and affects, and impulsiveness marked" concerns 4-6% of the general population. This is the emotional trouble the most associated with the occurence of suicide attempts (85% of these patients make multiple suicide attempts) and death by suicide (10% of these patients). This is a major public health problem.
A large number of patients with borderline personality disorder are not informed of their diagnosis. The main reasons are : the non-recognition of this disorder by health professionals, the belief that borderline personality disorder is a overly stigmatizing diagnosis , or preference to diagnose another disorder - that professionals think respond better to treatments and therefore be of a better prognosis.
Patients with borderline personality disorder often think themselves as "bad people" or the only people suffering from these symptoms. Thus, the ignorance of borderline personality disorder by patients leads to a basis of their altered sense of identity, perceived as defective or isolated. This generate a strong internalized stigma.
Many people diagnosed with borderline personality disorder receive no information about this disorder while psychoeducation has shown its effectiveness in severe psychiatric disorders, including the disorder of borderline personality, by reducing the negative repercussions psychiatric pathology. Moreover, the education of patients suffering from self-stigma makes it possible to in the face of negative beliefs around the disease and the acquisition of knowledge about the disorder and how to deal with it reduces self-stigma in bipolar patients. However, the propensity to feel shame - the stigmatization of oneself as worthless - is strongest in borderline personality disorder compared to all psychiatric disorders and most associated with the occurence of suicidal behaviors. In recommendations with good clinical practice, the investigator propose within the sector a day of education on borderline personality disorder including a transmission of current scientific knowledge on the illness, a dimensional understanding of the disorder, and the dis-identification of self to the symptoms of borderline personality disorder. The investigator hypothesize that this day of psychoeducation makes it possible to decrease self-stigma, which could be a mediator in reducing negative repercussions of borderline pathology.
- Conditions
- Borderline Personality Disorder
- Being tested
- Psychoeducation day on borderline personality disorder
- Keywords
- Psychoeducation day, internalized stigmatization
- Medical subject headings
- Borderline Personality Disorder
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Psychoeducation day on borderline personality disorderOther
Transmission of latest knowledge on borderline personality disorder
What is being measured
The primary outcome is the main question the study is designed to answer.
Comparison of internalized stigma of mental illnessillness
Comparison of internalized stigma of mental illness between pre-treatment
Measured: At immediate post-intervention
Comparison of internalized stigma of mentalillness
Comparison of internalized stigma of mental illness between pre-treatment
Measured: At 3 months post-intervention
Secondary outcomes (20)
Depressive symptoms using the Beck Depression Inventory
Comparison of depressive symptoms between pre-treatment and post-intervention
Measured: At immediate post-intervention
Depressive symptoms using the Beck Depression Inventory
Comparison of depressive symptoms between pre-treatment and 3 months post-intervention
Measured: At 3 months post-intervention
Severity of suicidal ideation evaluated by the likert scales from 0 (none) to 10 (maximum possible suicidal ideation)
Comparison of the intensity of suicidal ideation between pre-treatment and post-intervention
Measured: At immediate post-intervention
Severity of suicidal ideation evaluated by the likert scales from 0 (none) to 10 (maximum possible suicidal ideation)
Comparison of the intensity of suicidal ideation between pre-treatment and 3 months post-intervention
Measured: At 3 months post-intervention
Psychological pain using the Likert scales from 0 (none) to 10 (maximum possible pain)
Comparison of psychological pain between pre-treatment and post-intervention
Measured: At immediate post-intervention
Psychological pain using the Likert scales from 0 (none) to 10 (maximum possible pain)
Comparison of psychological pain between pre-treatment and 3 months post-intervention
Measured: At 3 months post-intervention
The intensity of hopelessness using the Likert scales from 0 (none) to 10 (maximum possible hopelessness)
Comparison of the intensity of hopelessness between pre-treatment and post-intervention
Measured: At immediate post-intervention
The intensity of hopelessness using the Likert scales from 0 (none) to 10 (maximum possible hopelessness)
Comparison of the intensity of hopelessness between pre-treatment and 3 months post-intervention
Measured: At 3 months post-intervention
The intensity of optimism using analog visual scale
Comparison of the intensity of optimism between pre-treatment and post-intervention
Measured: At immediate post-intervention
The intensity of optimism using analog visual scale
Comparison of the intensity of optimism between pre-treatment and 3 months post-intervention
Measured: At 3 months post-intervention
Feeling of pleasure using the quality of life questionnaire on pleasure and satisfaction
Comparison of feeling of pleasure between pre-treatment and post-intervention
Measured: At immediate post-intervention
Feeling of pleasure using the quality of life questionnaire on pleasure and satisfaction
Comparison of feeling of pleasure between pre-treatment and 3 months post-intervention
Measured: At 3 months post-intervention
Feeling of satisfaction using the quality of life questionnaire on pleasure and satisfaction
Comparison of feeling of satisfaction between pre-treatment and post-intervention
Measured: At immediate post-intervention
Feeling of satisfaction using the quality of life questionnaire on pleasure and satisfaction
Comparison of feeling of satisfaction between pre-treatment and 3 months post-intervention
Measured: At 3 months post-intervention
Anxiety state using the State-Trait Inventory (STAI-State)
Comparison of the state of anxiety between pre-treatment and post-intervention
Measured: At immediate post-intervention
Anxiety state using the State-Trait Inventory (STAI-State)
Comparison of the state of anxiety between pre-treatment and 3 months post-intervention
Measured: At 3 months post-intervention
Hopelessness using the Beck Hopelessness Scale (BHS)
Comparison of the hopelessness between pre-treatment and post-intervention
Measured: At immediate post-intervention
Hopelessness using the Beck Hopelessness Scale (BHS)
Comparison of the hopelessness between pre-treatment and 3 months post-intervention
Measured: At 3 months post-intervention
Level of positive and negative affects using the PANAS Scale
Comparison of level of positive and negative affects between pre-treatment and post-intervention
Measured: At immediate post-intervention
Level of positive and negative affects using the PANAS Scale
Comparison of level of positive and negative affects between pre-treatment and 3 months post-intervention
Measured: At 3 months post-intervention
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted23 Jun 2022
- Study start1 Jan 2021
- Primary completion1 Jan 2021
- Study completion1 Sep 2021
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Borderline Personality DisorderStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Retrospective
- Enrolment
- 50 participants (actual)
Sponsor and investigators
- Lead sponsor
- University Hospital, Montpellier
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT05428462
- Sponsor's protocol ID
- RECHMPL21_0611
- Acronym
- EDUC-BPD
- Status last verified
- May 2022
- First submitted
- 16 Jun 2022
- Last updated
- 5 Jul 2022
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Undecided: NC
Study at a glance
From the registry record, last updated by the sponsor on 5 Jul 2022. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Effectiveness of a One-day Psychoeducation Program on Internalized Stigmatization for Borderline Personality Disorder (BPD) Patients
- ClinicalTrials.gov ID
- NCT05428462
- Acronym / sponsor ID
- EDUC-BPD / RECHMPL21_0611
- Conditions
- Borderline Personality Disorder
- Keywords
- Psychoeducation day, internalized stigmatization
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 50 participants (actual)
- Lead sponsor
- University Hospital, MontpellierUniversity, hospital or other
- Study start
- 1 Jan 2021 (actual)
- Primary completion
- 1 Jan 2021 (actual)
- Study completion
- 1 Sep 2021 (actual)
- First posted
- 23 Jun 2022 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Education day on borderline personality disorder (BPD), including a transmission of current scientific knowledge on the disease. A dimensional understanding of BPD is delivered as well as disidentification of oneself to the symptoms of borderline personality disorder (Ducasse 2020 Eur Arch Psychiatry Clin Neurosci). The main objective is to evaluate the impact of borderline education day on self-stigma.
Detailed description
Borderline personality disorder defined as "a pattern of instability in interpersonal relationships, self-image and affects, and impulsiveness marked" concerns 4-6% of the general population. This is the emotional trouble the most associated with the occurence of suicide attempts (85% of these patients make multiple suicide attempts) and death by suicide (10% of these patients). This is a major public health problem.
A large number of patients with borderline personality disorder are not informed of their diagnosis. The main reasons are : the non-recognition of this disorder by health professionals, the belief that borderline personality disorder is a overly stigmatizing diagnosis , or preference to diagnose another disorder - that professionals think respond better to treatments and therefore be of a better prognosis.
Patients with borderline personality disorder often think themselves as "bad people" or the only people suffering from these symptoms. Thus, the ignorance of borderline personality disorder by patients leads to a basis of their altered sense of identity, perceived as defective or isolated. This generate a strong internalized stigma.
Many people diagnosed with borderline personality disorder receive no information about this disorder while psychoeducation has shown its effectiveness in severe psychiatric disorders, including the disorder of borderline personality, by reducing the negative repercussions psychiatric pathology. Moreover, the education of patients suffering from self-stigma makes it possible to in the face of negative beliefs around the disease and the acquisition of knowledge about the disorder and how to deal with it reduces self-stigma in bipolar patients. However, the propensity to feel shame - the stigmatization of oneself as worthless - is strongest in borderline personality disorder compared to all psychiatric disorders and most associated with the occurence of suicidal behaviors. In recommendations with good clinical practice, the investigator propose within the sector a day of education on borderline personality disorder including a transmission of current scientific knowledge on the illness, a dimensional understanding of the disorder, and the dis-identification of self to the symptoms of borderline personality disorder. The investigator hypothesize that this day of psychoeducation makes it possible to decrease self-stigma, which could be a mediator in reducing negative repercussions of borderline pathology.
Study design
- Observational model
- Cohort
- Time perspective
- Retrospective
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
- Study population
- The study population is patients with Borderline Personality disorder assesed according to the SCID II
Key inclusion criteria (2 listed)
- Patients with Borderline Personality disorder assessed according to SCID II
- Having attended the borderline education day
Key exclusion criteria (1 listed)
- None
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Psychoeducation day on borderline personality disorderTransmission of latest knowledge on borderline personality disorder | Other | – |
Primary outcome
Comparison of internalized stigma of mental illnessillness
Time frame: At immediate post-intervention
Comparison of internalized stigma of mental illness between pre-treatment
Comparison of internalized stigma of mentalillness
Time frame: At 3 months post-intervention
Comparison of internalized stigma of mental illness between pre-treatment
20 secondary outcomes
Depressive symptoms using the Beck Depression Inventory
Time frame: At immediate post-intervention
Depressive symptoms using the Beck Depression Inventory
Time frame: At 3 months post-intervention
Severity of suicidal ideation evaluated by the likert scales from 0 (none) to 10 (maximum possible suicidal ideation)
Time frame: At immediate post-intervention
Severity of suicidal ideation evaluated by the likert scales from 0 (none) to 10 (maximum possible suicidal ideation)
Time frame: At 3 months post-intervention
Psychological pain using the Likert scales from 0 (none) to 10 (maximum possible pain)
Time frame: At immediate post-intervention
Psychological pain using the Likert scales from 0 (none) to 10 (maximum possible pain)
Time frame: At 3 months post-intervention
The intensity of hopelessness using the Likert scales from 0 (none) to 10 (maximum possible hopelessness)
Time frame: At immediate post-intervention
The intensity of hopelessness using the Likert scales from 0 (none) to 10 (maximum possible hopelessness)
Time frame: At 3 months post-intervention
The intensity of optimism using analog visual scale
Time frame: At immediate post-intervention
The intensity of optimism using analog visual scale
Time frame: At 3 months post-intervention
Feeling of pleasure using the quality of life questionnaire on pleasure and satisfaction
Time frame: At immediate post-intervention
Feeling of pleasure using the quality of life questionnaire on pleasure and satisfaction
Time frame: At 3 months post-intervention
Feeling of satisfaction using the quality of life questionnaire on pleasure and satisfaction
Time frame: At immediate post-intervention
Feeling of satisfaction using the quality of life questionnaire on pleasure and satisfaction
Time frame: At 3 months post-intervention
Anxiety state using the State-Trait Inventory (STAI-State)
Time frame: At immediate post-intervention
Anxiety state using the State-Trait Inventory (STAI-State)
Time frame: At 3 months post-intervention
Hopelessness using the Beck Hopelessness Scale (BHS)
Time frame: At immediate post-intervention
Hopelessness using the Beck Hopelessness Scale (BHS)
Time frame: At 3 months post-intervention
Level of positive and negative affects using the PANAS Scale
Time frame: At immediate post-intervention
Level of positive and negative affects using the PANAS Scale
Time frame: At 3 months post-intervention
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 5 Jul 2022.
- Individual participant dataSharing planned: Undecided. NC
Related trials for Borderline Personality Disorder
Recruiting
Combining Transcranial Magnetic Stimulation With Emotion Regulation Skills Training in Borderline Personality Disorder
Borderline Personality Disorder (BPD)
RecruitingPhase 2
MDMA in Borderline Personality Disorder
Borderline Personality Disorder
Active, not recruitingPhase 2
Mindfulness-based Neurofeedback to Augment Psychotherapy for Adults With Borderline Personality Disorder
Borderline Personality Disorder
Recruiting
Predictors of Clinical Course and Treatment Response in DBT Programmes
Self Harm, Borderline Personality Disorder
Recruiting
Effectiveness of Enhanced Dialectical Behavior Therapy Skills Training Group for Borderline Personality Disorder
Borderline Personality Disorder (BPD), Dialectical Behavior Therapy
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Borderline Personality Disorder, run by University Hospital, Montpellier at 1 site in France.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 2 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 5 Jul 2022. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Comparison of internalized stigma of mental illnessillness (time frame: At immediate post-intervention). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 5 Jul 2022.